GRP and small cell lung carcinoma: A meta-analysis of 27 studies found that serum ProGRP Is a reliable blomarker for diagnosing small cell lung cancer, with a pooled sensitivity of 75.4% and specificity of 94.5%, Indicating a strong ability to detect the disease.